Drug
Pg4 Multivalent Vaccine
Pg4 Multivalent Vaccine: highest development phase Phase 3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| PG4 Multivalent Vaccine NCT07794748 | Phase 3 | Pneumococcal Disease |
Latest
No recent events.
Follow Pg4 Multivalent Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.